World Rare Disease Day: ABIONYX renews its commitment to treat LCAT Deficiency (Norum's disease) and provides an update on its advances
ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a next generation biopharma company dedicated to the development of innovative biomedicines based on a recombinant apolipoprotein apoA-1 for the treatment of the most severe inflammatory diseases, today provides an update on its progress and confirms its commitment to the rare disease known as LCAT Deficiency or 'Norum's disease'.
About ABIONYX Pharma
ABIONYX Pharma is a next-generation biopharma company dedicated to the development of innovative biomedicines for the most severe inflammatory diseases for which there is no effective or existing treatment, even in the rarest indications. The company accelerates the development of breakthrough therapies thanks to in-depth expertise in lipid science and a technological platform based on recombinant apoA-I. ABIONYX Pharma is committed to radically improving the results of sepsis treatments and intensive care.
CONTACT: NewCap
Investor relations
Nicolas Fossiez
Louis-Victor Delouvrier
[email protected]
+33 (0)1 44 71 98 53NewCap
Media relations
Arthur Rouillé
+33 (0)1 44 71 00 15
KEYWORD: MICHIGAN EUROPE UNITED STATES NORTH AMERICA FRANCE
SOURCE: ABIONYX Pharma
Copyright Business Wire 2025.
PUB: 02/28/2025 01:30 AM/DISC: 02/28/2025 01:30 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
One A Day® Launches First of its Kind Multivitamin Gummy with Iron to Help Fill Nutrient Gaps in Kids
One A Day® Kids Multi with Iron provides 2/3 of the recommended daily value of Iron and is one of three offerings in the new Kids' line WHIPPANY, N.J., July 23, 2025--(BUSINESS WIRE)--One A Day®, the multivitamin and supplement brand rooted in 80+ years of nutritional science, announced the launch of One A Day® Kids Multi with Iron, a gummy multivitamin with 12mg of iron per serving1—no kids multivitamin gummy among leading brands has more iron—to help fill nutrient gaps kids may have. Iron is an essential mineral for healthy growth and development. As picky eating behavior is common according to a new survey sponsored by One A Day®, children may be falling short of important nutrients like iron. The survey sponsored by One A Day® reveals that mealtime can often feel like a standoff for parents and kids, with approximately two-thirds (66%) sharing that their child refuses meals at least once a week and more than half (54%) say their child mostly eats snacks, while refusing full meals. This can make it challenging to help kids get enough of the key nutrients they may need for healthy development and highlights the need for nutritional support during this picky phase. The survey also found that over half (51%) of parents worry their child's eating habits will affect growth and development, with 46% saying that managing their child's eating habits is a top parenting concern – even ahead of screentime. To shed light on the ways that parents can help kids get enough daily nutrients, One A Day® Kids is partnering with Dr. Jessica Andrade, board certified pediatrician. "Through my experience working with children and their families, I know how important good, balanced nutrition is for supporting kids' healthy development," shares Dr. Andrade. "Iron is one of the most common nutritional deficiencies in children, and it is crucial to their development. Adding these vitamin gummies to children's daily routines is a simple and tasty way to help meet daily iron needs, especially when they may lack iron in their diets." One A Day® Kids Multi with Iron is one of three offerings in the new One A Day Kids' line. These easy-to-chew gummy multivitamins are specially formulated with key nutrients for kids to support overall healthy growth and development as well as eye, brain, and immune health. One A Day® Kids Multi with Iron Gummies provides key nutrients and an excellent source of iron with 12mg of iron in two gummies a day – providing ⅔ of the recommended Daily Value for this key nutrient. One A Day® Kids Multi With Probiotic Gummies contains essential nutrients, and a probiotic clinically tested in kids. It includes 1 billion CFUs of Bacillus Subtilis DE111® probiotic per serving (2 gummies) to support gut health. One A Day® Kids Multi Gummies is formulated with 9 key vitamins and minerals, offering nutritional support in delicious natural fruit flavors orange, raspberry, and cherry2. "As a brand dedicated to providing consumers with nutritional support at important life stages, we know how important it is for parents to have a trusted multivitamin that kids actually want to take because they like the taste and texture. That's why we are excited to introduce the new One A Day® Kids line including the first of its kind gummy multivitamin with iron for kids," says Lisa Perez, mom of three and General Manager Nutritionals at Bayer, the maker of One A Day®. One A Day® Kids Gummies are formulated with good stuff parents want, without stuff they don't: free of artificial sweeteners, high fructose corn syrup and egg, fish/crustacean shellfish, and dairy (milk) – making them a great option for helping little ones thrive. With this launch, One A Day® reaffirms its commitment to providing consumers with high-quality multivitamins specially designed for different life stages, genders, ages, or health goals. For more information on One A Day® Kids, visit Benefit claims for One A Day(R) Kids Multi Gummies have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. DE111(R) is a trademark of Deerland Probiotics & Enzymes, Inc. 1 One serving = two gummies 2 Natural orange, raspberry and cherry flavors with other natural flavors Research MethodologyBayer sponsored an online survey for One A Day® Vitamins from 3/19/2025 to 3/23/2025 to explore how pickiness manifests in children and understand the real-life impact it has on parents. The survey included 1,000 U.S. adults with children ages 4-10 years old, balanced by gender and region to reflect U.S. census demographics. About One A Day®One A Day is a multivitamin and supplement brand offering specially formulated products for many members of the family. From prenatal to 65+, One A Day offers products for different ages, genders and health goals. The portfolio includes tablet, softgel, capsule, and gummy products. One A Day products are available at most major drug stores and retailers nationwide. About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. View source version on Contacts Jan SchlegelmilchDirector, Integrated Communications, U.S. Consumer Bryan GibbsVice President, Media, twelvenote agencybgibbs@ Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
NCR Voyix to Release Second Quarter 2025 Earnings Results
ATLANTA, July 23, 2025--(BUSINESS WIRE)--NCR Voyix Corporation (NYSE: VYX), a leading global provider of digital commerce solutions, will report financial results for the second quarter 2025 before the market opens on Thursday, August 7, 2025. The NCR Voyix management team will host a conference call at 8:00 a.m. ET the same day to discuss the financial results. Conference Call Details Date and time: August 7, 2025 | 8:00 a.m. ET Dial In Number: (877) 407-3088 (Toll free) | +1 (201) 389-0927 (Toll) A live webcast of the conference call and related presentation materials will be available on the company's investor relations website at A replay of the webcast will be available on the company's investor relations website following the live event. About NCR Voyix NCR Voyix Corporation (NYSE: VYX) is a leading global provider of digital commerce solutions for the retail and restaurant industries. NCR Voyix transforms retail stores and restaurant systems through experiences with comprehensive, platform-led SaaS and services capabilities. NCR Voyix is headquartered in Atlanta, Georgia, with customers in more than 30 countries across the globe. View source version on Contacts Investor Relations:Sarah Jane Media Relations: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Dynatrace to Report First Quarter Fiscal Year 2026 Financial Results
BOSTON, July 23, 2025--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, today announced that it will report financial results for its first quarter of fiscal year 2026 ended June 30, 2025 before the U.S. financial markets open on August 6, 2025. In conjunction with this report, Dynatrace will host a conference call and live webcast to discuss the company's financial results and its business outlook. Conference Call DetailsThe conference call will begin at 8:00 a.m. Eastern Time on August 6, 2025. To access the conference call from the U.S. and Canada, dial (866) 405-1247, or internationally, dial (201) 689-8045 with conference ID # 13754900. The call will also be available live via webcast on the company's website, An audio replay of the call will be available until 11:59 p.m. Eastern Time on November 4, 2025 by dialing (877) 660-6853 from the U.S. or Canada, or for international callers by dialing (201) 612-7415 and entering conference ID # 13754900. In addition, an archived webcast will be available at About DynatraceDynatrace (NYSE: DT) is advancing observability for today's digital businesses, helping to transform the complexity of modern digital ecosystems into powerful business assets. By leveraging AI-powered insights, Dynatrace enables organizations to analyze, automate, and innovate faster to drive their business forward. To learn more about Dynatrace, visit visit our blog and follow us on LinkedIn and X @dynatrace. Dynatrace and the Dynatrace logo are trademarks of the Dynatrace, Inc. group of companies. All other trademarks are the property of their respective owners. © 2025 Dynatrace LLC. View source version on Contacts Investor Contact: Noelle FarisVP, Investor Relationsir@ Media Relations: Dynatrace PR Teampr-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
